证券代码：002799 证券简称：环球印务 公告编号：2025-017 西安环球印务股份有限公司 关于2024年度拟不进行利润分配的专项说明 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、审议程序 西安环球印务股份有限公司（以下简称"公司"）于 2025 年 4 月 24 日召开 了第六届董事会第十一次会议和第六届监事会第十次会议，全票审议通过了 《2024 年度利润分配预案》的议案，该议案尚需提交 2024 年度股东大会审议。 二、公司 2024 年度利润分配预案 经希格玛会计师事务所（特殊普通合伙）审计，母公司 2024 年度实现净利 润-120,631,757.30 元。根据《中华人民共和国公司法》《企业会计准则》及《西 安环球印务股份有限公司章程》（以下简称"《公司章程》"）等规定，公司拟按照 2024 年度实现净利润 10%提取法定盈余公积 0 元，截至 2024 年 12 月 31 日，母 公司可供股东分配的利润为 101,366,008.12 元。 公司拟定 2024 年度利润分配方案为：不进行利润分配，不送红股，也不进 行资本公积金转增股 ...

独立董事述职报告（李留闯） 西安环球印务股份有限公司 独立董事 2024 年度述职报告 各位股东及股东代表： 本人作为西安环球印务股份有限公司（以下简称"公司"）的独立董事，在 根据《公司法》《上市公司独立董事管理办法》《上市公司独立董事履职指引》 《上市公司治理准则》《公司章程》《公司独立董事工作制度》及有关法律法规 的规定和要求，认真履行职责，充分发挥独立董事的独立性和专业性的作用， 维护公司整体利益，维护全体股东尤其是中小股东的合法权益。现将 2024 年度 本人履行独立董事职责情况述职如下： 一、独立董事的基本情况 李留闯，男，1986 年 11 月出生，中国国籍，博士学历，无境外居留权。现 任公司独立董事。主要工作经历：2013 年 11 月至 2015 年 10 月，任西北工业大 学会计讲师。2015 年 11 月至今，任西安交通大学会计讲师、副教授、教授，入 选"西安交通大学青年拔尖人才计划"；研究主要集中在会计和审计的制度安排 及其经济后果，包括会计信息披露、审计监管和注册会计师执业行为等。 2024 年度，本人任职符合《上市公司独立董事管理办法》第六条规定的独立 性要求，不存在影响独立性的情 ...

独立董事述职报告（张军礼） 西安环球印务股份有限公司 独立董事 2024 年度述职报告 各位股东及股东代表： 本人作为西安环球印务股份有限公司（以下简称"公司"）的独立董事，在 根据《公司法》《上市公司独立董事管理办法》《上市公司独立董事履职指引》 《上市公司治理准则》《公司章程》《公司独立董事工作制度》及有关法律法规 的规定和要求，认真履行职责，充分发挥独立董事的独立性和专业性的作用， 维护公司整体利益，维护全体股东尤其是中小股东的合法权益。现将 2024 年度 本人履行独立董事职责情况述职如下： 一、独立董事的基本情况 张军礼，男，1963 年 11 月出生，中国国籍，大学本科学历，无境外居留权。 现任公司独立董事。主要工作经历：1987 年 7 月至 2010 年 8 月，历任陕西省高 级人民法院法官培训中心副主任，咸阳中级法院副院长，省法院民三庭庭长；2010 年 8 月至 2021 年 8 月，任陕西省地方电力集团有限公司总法律顾问；2021 年 8 月至 2023 年 11 月，任国家电网陕西股份有限公司协理。现任西安市仲裁委员会 仲裁员。 2024 年度，本人任职符合《上市公司独立董事管理办法》 ...

西安环球印务股份有限公司董事会 关于独立董事独立性自查情况的专项意见 西安环球印务股份有限公司（以下简称"公司"）董事会共有三 位在任独立董事，分别为张军礼先生、冯涛先生、李留闯先生。 公司董事会收到三位独立董事提交的《独立董事关于独立性的自 查报告》，公司董事会对三位独立董事的独立性情况进行了核查与评 估，并出具如下专项意见： 西安环球印务股份有限公司 董 事 会 二〇二五年四月二十四日 1 经核查公司独立董事张军礼先生、冯涛先生、李留闯先生的任职 经历以及签署的相关自查文件，上述人员未在公司担任除独立董事以 外的任何职务，也未在公司主要股东公司担任任何职务，与公司以及 主要股东之间不存在利害关系或其他可能妨碍其进行独立客观判断 的关系，不存在影响独立董事独立性的情况，均严格遵守《公司法》 《上市公司治理准则》和《上市公司独立董事管理办法》等法律法规 中对独立董事独立性的相关要求。 ...

独立董事述职报告（冯涛） 西安环球印务股份有限公司 独立董事 2024 年度述职报告 各位股东及股东代表： 本人作为西安环球印务股份有限公司（以下简称"公司"）的独立董事，在 根据《公司法》《上市公司独立董事管理办法》《上市公司独立董事履职指引》 《上市公司治理准则》《公司章程》《公司独立董事工作制度》及有关法律法规 的规定和要求，认真履行职责，充分发挥独立董事的独立性和专业性的作用， 维护公司整体利益，维护全体股东尤其是中小股东的合法权益。现将 2024 年度 本人履行独立董事职责情况述职如下： 一、独立董事的基本情况 冯涛，男，1956 年 10 月出生，中国国籍，博士学历，无境外居留权。现任 公司独立董事。主要工作经历：历任陕西财经学院系主任、西安交通大学经济与 金融学院副院长、西安交通大学经济金融学院证券研究所所长，教授、博士生导 师、西安市社科联副主席，陕西省中华外国经济学会会长等职务。现任陕西省政 府决策咨询委财政金融组委员、西安市决策咨询委财政金融组组长；2023 年 2 月 至今，任港股西部水泥（02233.HK）独立非执行董事。 2024 年度，本人任职符合《上市公司独立董事管理办法》第六条 ...

Group 1 - The core point of the article is that Global Printing (002799) reported a revenue of 1.397 billion yuan for 2024, representing a year-on-year decline of 12.77% [1] - The net loss attributable to shareholders of the listed company was 52.3768 million yuan, compared to a net loss of 222 million yuan in the same period last year [1] - The basic earnings per share were -0.16 yuan per share [1] Group 2 - The company plans not to distribute cash dividends, nor to issue bonus shares, and will not increase share capital from reserves [1]

Financial Performance - The company's revenue for Q1 2025 was ¥238,088,289.33, a decrease of 47.12% compared to ¥450,203,926.44 in the same period last year[5] - The net profit attributable to shareholders was a loss of ¥3,682,535.47, representing a decline of 116.12% from a profit of ¥22,838,254.18 in the previous year[5] - The basic earnings per share decreased to -¥0.01, down 114.29% from ¥0.07 in the same period last year[5] - Net profit for the period was a loss of ¥4,236,258.47, compared to a profit of ¥24,239,425.41 in the previous period, indicating a significant decline[28] - The total comprehensive income for the period was -4,236,258.47, compared to 24,239,425.41 in the previous period[29] Cash Flow and Assets - The net cash flow from operating activities increased by 68.42% to ¥50,192,710.32, up from ¥29,801,550.08 year-on-year[5] - The company's cash and cash equivalents increased slightly to ¥526,830,684.60 from ¥521,050,078.73, showing a growth of approximately 1.5%[23] - The total cash and cash equivalents at the end of the period were 495,457,509.47, slightly down from 484,301,578.58 in the previous period[32] - The net cash flow from investing activities was -11,681,813.91, compared to -36,526,271.43 in the previous period[32] - Cash flow from financing activities resulted in a net outflow of -39,474,050.55, an improvement from -44,947,907.01 in the previous period[32] Operating Costs and Liabilities - Total operating revenue decreased to ¥238,088,289.33 from ¥450,203,926.44, representing a decline of approximately 47% year-over-year[27] - Total operating costs decreased to ¥244,198,095.66 from ¥422,056,031.19, reflecting a reduction of about 42% year-over-year[27] - Total liabilities decreased to ¥664,299,801.23 from ¥699,521,287.01, a reduction of approximately 5%[25] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 21,964[11] - The largest shareholder, Shaanxi Pharmaceutical Holdings Group, holds 36.42% of the shares, totaling 116,550,000 shares[11] Impairment and Provisions - The company recognized an impairment loss of CNY 108,096,828.78 related to goodwill due to a decrease in the recoverable amount of the asset group associated with goodwill[14] - As of September 30, 2024, the company has made a provision for bad debts amounting to CNY 309,941,501.11, with a cumulative provision ratio of 90% for receivables from a client listed in the operating abnormality directory[14] - The company has made a provision for bad debts of CNY 39,891,890.14 for receivables from the same client, increasing the cumulative provision to CNY 332,614,418.97, with a cumulative provision ratio of 96.58%[14] Government Support and Subsidies - The company received government subsidies amounting to ¥173,561.32, which are closely related to its normal business operations[6] Strategic Initiatives - The company plans to establish a new company, Beijing Jinyinlian, with a registered capital of no less than CNY 80 million, for a new materials project with a total investment of no less than CNY 100 million[17] - The first phase of the "Global Printing Expansion and Green Packaging Intelligent Manufacturing Industrial Park" project has completed basic construction and some production lines have been successfully installed and commissioned[16] - The company has decided to shrink its internet digital marketing segment to enhance overall operational efficiency and optimize resource allocation[21] - The company has proposed to liquidate and deregister its subsidiary Yiboluo to optimize resource allocation and improve operational quality[20] - The company is actively pursuing legal avenues to recover overdue receivables, although no substantial results have been achieved yet[15] Research and Development - The company reported a significant increase in research and development expenses to ¥12,312,141.46 from ¥11,837,435.75, an increase of about 4%[28] Inventory and Receivables - Accounts receivable decreased to ¥205,331,642.57 from ¥225,907,400.74, a reduction of about 9%[23] - Inventory decreased to ¥73,559,387.13 from ¥82,051,035.90, indicating a decline of approximately 10%[24] Asset Utilization - The company has initiated a public leasing process for idle assets to enhance asset utilization and increase revenue[19]

Financial Performance - The company's operating revenue for 2024 was CNY 1,396,537,041.72, a decrease of 12.77% compared to CNY 1,600,910,936.87 in 2023[20] - The net profit attributable to shareholders for 2024 was a loss of CNY 52,376,848.32, an improvement of 76.40% from a loss of CNY 221,928,603.35 in 2023[20] - The cash flow from operating activities for 2024 was CNY 103,272,211.17, down 23.23% from CNY 134,527,227.60 in 2023[20] - The basic earnings per share for 2024 was -CNY 0.16, a 76.81% improvement from -CNY 0.69 in 2023[20] - Total assets at the end of 2024 were CNY 2,052,769,508.03, a decrease of 4.15% from CNY 2,141,654,413.64 at the end of 2023[20] - The net assets attributable to shareholders at the end of 2024 were CNY 1,290,358,423.10, down 4.72% from CNY 1,354,256,711.42 at the end of 2023[20] - The company reported a quarterly operating revenue of CNY 450,203,926.44 in Q1 2024, with a net profit of CNY 22,838,254.18 attributable to shareholders[24] - The company experienced a significant loss in Q4 2024, with a net profit attributable to shareholders of -CNY 79,840,892.77[24] - The company achieved a total operating revenue of 1.397 billion yuan, a year-on-year decrease of 12.77%, while the net profit attributable to shareholders was -52 million yuan, an increase of 76.40% year-on-year[54] Government Subsidies and Non-Recurring Items - In 2024, the company reported a government subsidy of approximately ¥1.73 billion, a decrease of 10.7% from ¥1.94 billion in 2023[26] - The total non-recurring profit and loss items amounted to approximately ¥2.61 billion in 2024, down from ¥3.87 billion in 2023, reflecting a decline of 32.5%[27] - The company experienced a non-operating income and expenses loss of approximately ¥740.22 million in 2024, an improvement from a loss of ¥1.35 billion in 2023[26] Market Trends and Business Focus - The pharmaceutical packaging market in China is projected to reach nearly ¥300 billion by 2025, with a compound annual growth rate (CAGR) of over 8%[29] - The company focuses on providing integrated packaging solutions in the pharmaceutical sector, enhancing supply chain management for clients[33] - The consumer packaging segment is shifting towards environmentally friendly materials, with a strong emphasis on paper packaging due to rising environmental standards[34] - The internet digital marketing business faced significant challenges, with revenue and gross profit declining due to overdue accounts receivable and increased competition[32] Technological Advancements and Innovations - The company has accumulated 241 intellectual property rights, including 156 patents and 85 software copyrights, showcasing its strong capabilities in technological innovation[43] - The company is committed to continuous innovation and investment in advanced technologies such as big data and AI to improve its core competitiveness[71] - The company has completed the development of automatic coding positioning technology, achieving a positioning accuracy of ±0.2mm and a speed improvement of 50% compared to traditional methods[75] - The company is developing a new anti-counterfeiting technology that reduces the probability of product counterfeiting to nearly zero, aiming to capture a significant share of the anti-counterfeit packaging market[76] Environmental and Social Responsibility - The company has received the EcoVadis Gold rating for its outstanding performance in corporate social responsibility, demonstrating its commitment to environmental, social, and governance practices[48] - The company focuses on green production and smart manufacturing, investing in environmental protection and digital transformation of production equipment[41] - The company is enhancing its product offerings with antibacterial coatings, which will meet higher customer demands and improve health safety[77] Management and Governance - The company has a high-level management team and a performance-oriented compensation system, enhancing its internal growth dynamics and market competitiveness[46] - The company has a total of four independent directors, ensuring compliance with governance standards[164] - The company has undergone significant management restructuring, with multiple appointments and departures, including the hiring of Xia Meiying as Chief Accountant[167] - The company is actively engaging in board member elections to ensure governance continuity and strategic oversight[166] Future Outlook and Strategic Initiatives - The company plans to utilize up to CNY 180 million of idle raised funds temporarily to supplement working capital, with a repayment period not exceeding 12 months from the board's approval date[102] - The company is focusing on developing anti-counterfeiting packaging technology to enhance safety in pharmaceutical packaging, aiming to secure a significant market share[72] - The company plans to expand its product line and market share in the aluminum tube sector while exploring new packaging products beyond aluminum tubes[114] - The company is committed to maintaining compliance with tax regulations to avoid potential impacts on net profit from changes in tax incentives[136]

证券代码：002799 证券简称：环球印务 公告编号：2025-009 西安环球印务股份有限公司 本公司及全体监事保证本公告内容真实、准确和完整，没有虚假记载、误 导性陈述或者重大遗漏。 一、监事会会议召开情况 西安环球印务股份有限公司（以下简称"公司"）第六届监事会第九次会议于 2025 年 4 月 2 日上午 11：00 在公司会议室以现场及通讯方式召开。会议通知已于 2025 年 3 月 26 日以邮件、书面通知等方式通知了全体监事。应出席本次会议的监事 3 名，实际 出席监事 3 名（监事赵坚先生以通讯表决方式参会）。会议由监事会主席史晓婷女士主 持。本次会议召集和召开程序符合《中华人民共和国公司法》和《西安环球印务股份有 限公司章程》（以下简称"《公司章程》"）的规定。 二、监事会会议审议情况 经全体与会监事认真审议，作出决议如下： 经审核，监事会认为：公司本次调整募投项目部分设备，是公司根据募投项目的实 际需要所作出的决定，未改变募投项目实施主体、实施方式、实施地点、募集资金用途、 募集资金投资金额，不存在变更或变相改变募集资金用途、影响公司正常经营以及损害 股东利益等情形，本次调整只涉及购买设备 ...

中信证券股份有限公司 关于西安环球印务股份有限公司 为规范公司募集资金管理和使用，保护投资者权益，公司设立了相关募集资 金专项账户。募集资金到账后，已全部存放于募集资金专项账户内，并与保荐机 构、存放募集资金的商业银行签署了募集资金三方、四方监管协议。 二、募投项目概况 公司本次非公开发行股票募集资金扣除发行费用后投入募集资金金额如下： 1 单位：万元 | 序号 | 项目名称 | 投资总额 | 拟投入募集资 金金额 | 实施主体 | | --- | --- | --- | --- | --- | | 1 | 环球印务扩产暨绿色包装 智能制造工业园（一期） | 59,813.37 | 55,000.00 | 西安凌峰环球印务 科技有限公司 | | | 项目 | | | | | 2 | 医药包装折叠纸盒扩产暨 | 28,023.18 | 8,753.26 | 天津滨海环球印务 | | | 智能制造项目 | | | 有限公司 | | 3 | 补充流动资金 | 10,000.00 | 10,000.00 | 西安环球印务股份 | | | | | | 有限公司 | | 合计 | / | 97,836.55 | 73,7 ...